A large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.
John Jarvis, BA
Advertisement
Articles by John Jarvis, BA
Advertisement
Latest Updated Articles
- Cost Impact of Switching From Metoprolol to Nebivolol for Hypertension
Published: June 22nd 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
Mind the Gap: Pharmacy’s Future as AI Evolves in Health Care
5
